Listen

IV Been There Too: Safely and Effectively Incorporating Technology and a Designated Person in USP <797> Compliance

There is a potpourri of questions surrounding the new USP <797> updates and many pharmacists and pharmacy technicians are unclear on how to obtain answers. As more facilities use technology and incorporate a designated person, it is crucial for best practice use cases to be shared among pharmacists, pharmacy technicians, and medication safety officers, so these healthcare professionals may learn ways to overcome common challenges in different scenarios. This educational activity will describe opportunities to implement and validate technology for sterile compounding, achieve organizational buy-in, and describe a use case where technology was safely and effectively integrated and USP <797> compliant. This activity will also highlight an example of incorporating a designated person and their experiences, challenges, and future opportunities.

Tuesday, April 22
12 - 1 p.m. ET

Registration is required for this webinar.

Webinar Registration

Speakers

Patricia C. Kienle, RPh, MPA, BCSCP, FASHP, Moderator
Director, Accreditation and Medication Safety
Cardinal Health
Wilkes-Barre, Pennsylvania

Kevin N. Hansen, PharmD, MS, BCSCP
Senior Director, Pharmacy Compounding Services
Premier Inc.
Charlotte, North Carolina

George Smith, PharmD, BCPS, BCSCP
System Sterile Compounding Services Specialist
Prisma Health
Sterile Compounding Clinical Instructor
University of South Carolina College of Pharmacy; Kennedy Pharmacy Innovation Center
Columbia, South Carolina

Glen Gard, CPhT-Adv, CSPT, FNHIA
National Director, Sterile Compounding & Pharmacy Compliance
Option Care Health
Chicago, Illinois

Target Audience

The target audience for the education is pharmacists, pharmacy technicians and medication safety officers practicing in hospitals and health systems, including all settings responsible for preparing, labeling, packaging, storing and distributing compounded sterile preparations. This also may be of interest to infection control practitioners and risk management practicing in hospitals and health systems.

Learning Objectives

Evaluate opportunities to safely and effectively incorporate technology into sterile compounding aligning with USP <797> standards.
Apply best practices for overcoming challenges with the use of designated persons.

Agenda

12 p.m. - Welcome and Introductions
Patricia C. Kienle
12:05 p.m. - The Roadmap to Implementing USP <797> Technology
Kevin N. Hansen and George Smith
12:35 p.m. - A Day in the Life of a Designated Person
Glen Gard
12:50 p.m. - Faculty Discussion, Questions and Answers
All Faculty

Accredited for CPE

ACPE #: 0204-0000-24-401-L07-P/T
CE Credit: 1 contact hour (0.1 CEUs)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.